Mon, Jul 28, 2014, 6:18 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

ONYX Pharmaceuticals, Inc. Message Board

  • johnpapas893 johnpapas893 Jun 9, 2013 10:24 AM Flag

    Celgene

    In view of the exceptional efficacy reported for CRd (carfilzomib, revlimid, and low-dose dexamethasone) for NDMM patients, it is likely that this combo will emerge as the standard front-line treatment. In the event of a ONXX take-over, Celgene could be as much a logical acquirer (and perhaps a more likely one) as Bayer.

 
ONXX
124.700.00(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.